Press Releases Latest Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update Press Releases Year None202120202019201820172016201520142013 Nov 06, 2020 Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020 Nov 03, 2020 Theratechnologies Announces Departure Of Chief Commercial Officer Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020 Oct 16, 2020 Theratechnologies Appoints Two New Board Members Oct 15, 2020 Theratechnologies Announces Financial Results For The Third Quarter Of Fiscal 2020 Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH Oct 05, 2020 Theratechnologies To Announce Financial Results For Third Quarter 2020 Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5 Sep 21, 2020 Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population First page « Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 41 - 50 of 262
Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
Nov 06, 2020 Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020
Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020
Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH
Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
